Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis M Ruilope

Showing results (31-40 of 355) with videos related to

Pageof 36
Sort By:
Fundamental & Clinical Pharmacology|July 14, 2005
Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular riskJulian Segura, Luis M Ruilope
Advances in Chronic Kidney Disease|January 13, 2011
Hypertension in moderate-to-severe nondiabetic CKD patientsJulian Segura, Luis M Ruilope
Clinical Therapeutics|December 7, 2005
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertensionLuis M Ruilope, Julian Segura
Current Opinion in Nephrology and Hypertension|June 30, 2009
Should diuretics always be included as initial antihypertensive management in early-stage CKD?Julian Segura, Luis M Ruilope
Expert Opinion on Pharmacotherapy|October 28, 2010
ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendationsLuis M Ruilope, Julian Segura
Current Hypertension Reports|November 4, 2010
Dual-acting angiotensin receptor-neprilysin inhibitionJulian Segura, Luis M Ruilope
European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionJavier Díez, Luis M Ruilope
Clinical Therapeutics|January 30, 2004
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidenceLuis M Ruilope, Julian Segura
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
New-onset diabetes and antihypertensive therapy: comments on ALLHAT trialCristina Sierra, Luis M Ruilope
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 2, 2009
Kidney protection: a key target in the management of patients with diabetesLuis M Ruilope, Julian Segura
Pageof 36

Showing results (31-40 of 355) with videos related to

Sort By:
Pageof 36
Fundamental & Clinical Pharmacology|July 14, 2005
Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular riskJulian Segura, Luis M Ruilope
Advances in Chronic Kidney Disease|January 13, 2011
Hypertension in moderate-to-severe nondiabetic CKD patientsJulian Segura, Luis M Ruilope
Clinical Therapeutics|December 7, 2005
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertensionLuis M Ruilope, Julian Segura
Current Opinion in Nephrology and Hypertension|June 30, 2009
Should diuretics always be included as initial antihypertensive management in early-stage CKD?Julian Segura, Luis M Ruilope
Expert Opinion on Pharmacotherapy|October 28, 2010
ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendationsLuis M Ruilope, Julian Segura
Current Hypertension Reports|November 4, 2010
Dual-acting angiotensin receptor-neprilysin inhibitionJulian Segura, Luis M Ruilope
European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionJavier Díez, Luis M Ruilope
Clinical Therapeutics|January 30, 2004
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidenceLuis M Ruilope, Julian Segura
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
New-onset diabetes and antihypertensive therapy: comments on ALLHAT trialCristina Sierra, Luis M Ruilope
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 2, 2009
Kidney protection: a key target in the management of patients with diabetesLuis M Ruilope, Julian Segura
Pageof 36